Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney

Spremljeno u:
Bibliografski detalji
Izdano u:Arthritis Res Ther
Glavni autori: Miner, Jeffrey N., Tan, Philip K., Hyndman, David, Liu, Sha, Iverson, Cory, Nanavati, Payal, Hagerty, David T., Manhard, Kimberly, Shen, Zancong, Girardet, Jean-Luc, Yeh, Li-Tain, Terkeltaub, Robert, Quart, Barry
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Erratum
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5059967/
https://ncbi.nlm.nih.gov/pubmed/27733209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1150-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items